Movers

Sciensify
NASDAQStock moves explained

SMMT

Summit Therapeutics

Every big move we have covered on Summit Therapeutics, newest first. Each story gives the answer first and links to the filings and releases behind it.

Last covered move

Down −16.5%

Close that day$11.82

Figures are from the day of the story, not live quotes.

Why it moved that day

Stories about SMMT

Newest first. Moves and closes are for the day each story covers.

Filing history

Summit Therapeutics Inc. filings with the SEC from the last 180 days, newest first. We wrote about one of them.

Filings come straight from the SEC's EDGAR database and are listed automatically. They are not written or checked by us. Fetched .

Show all filings (28)Show key filings only

All 28 filings, including insider trade reports. Insider reports filed on the same day are grouped into one row.

November 20266 entries

  1. Results announced (earnings release)

    8-K

    Also: charter, bylaws or fiscal year changed, shareholder vote results

September 20264 entries

  1. Major agreement signed

    8-K

    Also: shares sold without registration, charter, bylaws or fiscal year changed, company update

Showing 23 key filings: company reports, results, annual and quarterly reports, proxies and offerings.

October 20261 entry

September 20264 entries

  1. Major agreement signed

    8-K

    Also: shares sold without registration, charter, bylaws or fiscal year changed, company update

Older filings on SEC.gov

Company profile

As registered with the SEC

Name on file
Summit Therapeutics Inc.
Listed on
Nasdaq SMMT
Industry
Pharmaceutical Preparations
Fiscal year ends
December 31
Headquarters
Miami, Florida
SEC filer category
Large accelerated filer
Latest annual report
Feb 23, 2026, 10-K on SEC.gov
Latest quarterly report
Nov 4, 2026, 10-Q on SEC.gov
SEC company ID (CIK)
1599298

All filings on EDGAR

Also moved on Nov 16

Other stocks in the same day's coverage

That day in Markets

These stories explain past price moves using public sources. They are not investment advice. See our disclaimer.